Western Pacific Wealth Management, LP Intellia Therapeutics, Inc. Transaction History
Western Pacific Wealth Management, LP
- $105 Million
- Q1 2025
A detailed history of Western Pacific Wealth Management, LP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Western Pacific Wealth Management, LP holds 500 shares of NTLA stock, worth $5,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$5,370
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
344Shares Held
98.4MCall Options Held
784KPut Options Held
713K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$140 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$115 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$103 Million0.0% of portfolio
-
State Street Corp Boston, MA4.51MShares$48.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.8MShares$40.8 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $816M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...